Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

被引:753
作者
Smith, Colette J. [1 ]
Ryom, Lene [2 ]
Weber, Rainer [3 ]
Morlat, Philippe [4 ]
Pradier, Christian [5 ]
Reiss, Peter [6 ,7 ]
Kowalska, Justyna D. [8 ]
de Wit, Stephane [9 ]
Law, Matthew [10 ]
el Sadr, Wafaa [11 ]
Kirk, Ole [2 ]
Friis-Moller, Nina [12 ]
Monforte, Antonella d'Arminio [13 ]
Phillips, Andrew N. [1 ]
Sabin, Caroline A. [1 ]
Lundgren, Jens D. [2 ]
机构
[1] UCL, Res Dept Infect & Populat Hlth, London NW3 2PF, England
[2] Univ Copenhagen, Rigshosp, CHIP, Dept Infect Dis 2100, DK-1168 Copenhagen, Denmark
[3] Univ Zurich, Univ Zurich Hosp, Div Infect Dis, Zurich, Switzerland
[4] Univ Bordeaux Segalen, CHU Bordeaux, Serv Med Intern & Malad Infect, Bordeaux, France
[5] Nice Univ Hosp, Dept Publ Hlth, Nice, France
[6] Univ Amsterdam, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands
[7] Stichting HIV Monitoring, Amsterdam, Netherlands
[8] Med Univ Warsaw, Dept Adults Infect Dis, Warsaw, Poland
[9] Hop Univ St Pierre, Dept Infect Dis, B-1000 Brussels, Belgium
[10] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia
[11] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA
[12] Odense Univ Hosp, Dept Infect Dis, Odense, Denmark
[13] San Paolo Univ Hosp, Dept Hlth Sci, Milan, Italy
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; AIDS-DEFINING CANCERS; ANTIRETROVIRAL THERAPY; MYOCARDIAL-INFARCTION; DATA-COLLECTION; ADVERSE EVENTS; RISK-FACTORS; HEPATITIS-C; MORTALITY; INFECTION;
D O I
10.1016/S0140-6736(14)60604-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background With the advent of effective antiretroviral treatment, the life expectancy for people with HIV is now approaching that seen in the general population. Consequently, the relative importance of other traditionally non-AIDS-related morbidities has increased. We investigated trends over time in all-cause mortality and for specific causes of death in people with HIV from 1999 to 2011. Methods Individuals from the Data collection on Adverse events of anti-HIV Drugs (D: A: D) study were followed up from March, 1999, until death, loss to follow-up, or Feb 1, 2011, whichever occurred first. The D: A: D study is a collaboration of 11 cohort studies following HIV-1-positive individuals receiving care at 212 clinics in Europe, USA, and Australia. All fatal events were centrally validated at the D: A: D coordinating centre using coding causes of death in HIV (CoDe) methodology. We calculated relative rates using Poisson regression. Findings 3909 of the 49 731 D: A: D study participants died during the 308 719 person-years of follow-up (crude incidence mortality rate, 12 7 per 1000 person-years [95% CI 12.3-13.1]). Leading underlying causes were: AIDS-related (1123 [29%] deaths), non-AIDS-defining cancers (590 [15%] deaths), liver disease (515 [13%] deaths), and cardiovascular disease (436 [11%] deaths). Rates of all-cause death per 1000 person-years decreased from 17 5 in 1999-2000 to 9 1 in 2009-11; we saw similar decreases in death rates per 1000 person-years over the same period for AIDS-related deaths (5 9 to 2 0), deaths from liver disease (2 7 to 0 9), and cardiovascular disease deaths (1 8 to 0 9). However, non-AIDS cancers increased slightly from 1 6 per 1000 person-years in 1999-2000 to 2 1 in 2009-11 (p=0.58). After adjustment for factors that changed over time, including CD4 cell count, we detected no decreases in AIDS-related death rates (relative rate for 2009-11 vs 1999-2000: 0 92 [0.70-1.22]). However, all-cause (0 72 [0.61-0.83]), liver disease (0 48 [0.32-0.74]), and cardiovascular disease (0 33 [0.20-0.53) death rates still decreased over time. The percentage of all deaths that were AIDS-related (87/256 [34%] in 1999-2000 and 141/627 [22%] in 2009-11) and liver-related (40/256 [16%] in 1999-2000 and 64/627 [10%] in 2009-11) decreased over time, whereas non-AIDS cancers increased (24/256 [9%] in 1999-2000 to 142/627 [23%] in 2009-11). Interpretation Recent reductions in rates of AIDS-related deaths are linked with continued improvement in CD4 cell count. We hypothesise that the substantially reduced rates of liver disease and cardiovascular disease deaths over time could be explained by improved use of non-HIV-specific preventive interventions. Non-AIDS cancer is now the leading non-AIDS cause and without any evidence of improvement.
引用
收藏
页码:241 / 248
页数:8
相关论文
共 33 条
  • [1] [Anonymous], 2012, INT J EPIDEMIOL, V41, P433, DOI DOI 10.1093/IJE/DYR164
  • [2] Antiretroviral Therapy Cohort Collaboration, 1996, CLIN INFECT DIS, V50, P1387
  • [3] Trends in mortality according to hepatitis C virus serostatus in the era of combination antiretroviral therapy
    Berenguer, Juan
    Alejos, Belen
    Hernando, Victoria
    Viciana, Pompeyo
    Salavert, Miguel
    Santos, Ignacio
    Gomez-Sirvent, Juan L.
    Vidal, Francesc
    Portilla, Joaquin
    Del Amo, Julia
    [J]. AIDS, 2012, 26 (17) : 2241 - 2246
  • [4] Risk factors for advanced liver fibrosis in HIV-infected individuals: role of antiretroviral drugs and insulin resistance
    Blanco, F.
    Barreiro, P.
    Ryan, P.
    Vispo, E.
    Martin-Carbonero, L.
    Tuma, P.
    Labarga, P.
    Medrano, J.
    Gonzalez-Lahoz, J.
    Soriano, V.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2011, 18 (01) : 11 - 16
  • [5] Bruyand M, 2013, 20 C RETR OPP INF CR
  • [6] Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the US
    Buchacz, Kate
    Baker, Rose K.
    Palella, Frank J., Jr.
    Shaw, Lauren
    Patel, Pragna
    Lichtenstein, Kenneth A.
    Chmiel, Joan S.
    Vellozzi, Claudia
    Debes, Rachel
    Henry, Keith
    Overton, E. Turner
    Bush, Timothy J.
    Tedaldi, Ellen
    Carpenter, Charles
    Mayer, Kenneth H.
    Brooks, John T.
    [J]. ANTIVIRAL THERAPY, 2013, 18 (01) : 65 - 75
  • [7] How harmful is hazardous alcohol use and abuse in HIV infection: Do health care providers know who is at risk?
    Conigliaro, J
    Gordon, AJ
    McGinnis, KA
    Rabeneck, L
    Justice, AC
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 33 (04) : 521 - 525
  • [8] Cardiovascular disease risk factors in HIV patients -: association with antiretroviral therapy.: Results from the DAD study
    Friis-Moller, N
    Weber, R
    Reiss, P
    Thiébaut, R
    Kirk, O
    Monforte, AD
    Pradier, C
    Morfeldt, L
    Mateu, S
    Law, M
    El-Sadr, W
    De Wit, S
    Sabin, CA
    Phillips, AN
    Lundgren, JD
    [J]. AIDS, 2003, 17 (08) : 1179 - 1193
  • [9] Causes of death among Danish HIV patients compared with population controls in the period 1995-2008
    Helleberg, M.
    Kronborg, G.
    Larsen, C. S.
    Pedersen, G.
    Pedersen, C.
    Gerstoft, J.
    Obel, N.
    [J]. INFECTION, 2012, 40 (06) : 627 - 634
  • [10] Differences in the causes of death of HIV-positive patients in a cohort study by data sources and coding algorithms
    Hernando, Victoria
    Sobrino-Vegas, Paz
    Carmen Burriel, M.
    Berenguer, Juan
    Navarro, Gemma
    Santos, Ignacio
    Reparaz, Jesus
    Angeles Martinez, M.
    Antela, Antonio
    Gutierrez, Felix
    del Amo, Julia
    [J]. AIDS, 2012, 26 (14) : 1829 - 1834